SynthesisCancer medicine2020

Using circulating tumor DNA as a novel biomarker to screen and diagnose hepatocellular carcinoma: A systematic review and meta-analysis.

Ziying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.